FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

GOP pushes to hold sanctuary jurisdictions’ ‘feet to the fire’ in state where Laken Riley was killed

FBI subpoena of phone records leaves Trump chief of staff ‘in shock’: report

BREAKING: Clintons to Testify Separately Thursday and Friday in House Epstein Probe

Media Breakup: Jasmine Crockett’s Campaign Reportedly Calls Cops on CNN, Escorts Another Reporter Out of Rally

Louisiana teacher arrested for alleged inappropriate behavior with a juvenile

Fiery explosion destroys Massachusetts home, injures mother and 2-year-old child

Supreme Court litigator convicted of tax evasion

‘Squad’ member claims State of the Union guest was arrested

Bill and Hillary Clinton to sit for back-to-back House Oversight depositions over Epstein ties

WATCH: JD Vance Says Dems Showed ‘Cowardice’ During Trump’s SOTU Address And Lack ‘Conviction’

Report: Bill Gates Privately Apologizes to His Foundation Over Epstein Ties, Admits ‘Affairs’ with Russians

‘Peaceful protest’ narrative at center of antifa terrorism trial

DHS says ICE agents will not be at polling places during midterms

Trump admin says VA benefits claims backlog below 100K for first time in 6 years: ‘Record levels of service’

Trump administration blocks Venezuela from paying Maduro’s legal bills amid federal charges

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”